Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== 🧬 SSTR1 (Somatostatin Receptor 1) ====== {{tag>neuropeptide receptor sstr1 somatostatin glioblastoma}} <WRAP info> SSTR1 is one of five G-protein-coupled somatostatin receptors involved in neurotransmission, hormone regulation, and tumor biology. </WRAP> <WRAP column 60%> === 🔹 1. Gene and Expression === * **Gene**: ''SSTR1'' * **Location**: Chromosome 14q13 * **Expression**: * Brain (especially cortex, hippocampus) * Pancreas, GI tract, pituitary * Downregulated in **glioblastoma** === 🔹 2. Function === * Gi/o-coupled receptor → ↓cAMP * Inhibits hormone secretion (e.g., GH, insulin) * CNS: modulates synaptic activity, neuroprotection * Antiproliferative and antiangiogenic effects </WRAP> <WRAP column 40%> </WRAP> <WRAP clear /> === 🔹 3. Clinical Relevance === * ↓ **SSTR1 in glioblastoma** = **poor prognosis** * Correlates with: * IDH1-wildtype * EGFR amplification * G-CIMP-negative subtype * May serve as a **prognostic biomarker** === 💊 4. Therapeutic Implications === * **Agonists**: octreotide, pasireotide * ↓ proliferation in GBM cell lines * **Potential strategies**: * Targeted therapy with SSTR1 agonists * Combined molecular profiling + treatment === 🔬 5. Ligands and Pathways === ^ Type ^ Example ^ Function ^ | Agonist | Octreotide | ↓ tumor cell growth | | Agonist | Pasireotide | Broader affinity (SSTR1/2/5) | | Antagonist | (under study) | Not clinically available | **Signaling Pathways Affected**: * ↓ Adenylyl cyclase → ↓ cAMP * CDKN1A-B upregulation * Modulation of JAK/STAT, NF-κB, TGF-β pathways ---- [[https://doi.org/10.1007/s00018-025-05687-9|📄 G-GarcÃa et al. (2025) – Full article]] sstr1.txt Last modified: 2025/04/25 09:23by 127.0.0.1